Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Dotmatics Biology Solution for Antibody Discovery Streamlines Data Collection and Workflows to Accelerate Antibody Research and Therapies
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the […]
Limaca Medical Receives FDA Breakthrough Device Designation
Limaca Medical (“Limaca”) announced today that its Precision-GI™ Endoscopic Ultrasound Biopsy Product has received a Breakthrough […]
LifeOmic Deploys AI Solution With xCures to Improve Cancer Research and Treatment
LifeOmic, a software company that leverages the cloud, machine learning and mobile devices to power […]
Amniotics AB Announces Positive Pre-clinical Proof-of-concept Results for PulmoStem™ in End-stage Lung Disease
Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announced that PulmoStem™ significantly reduces the incidence of […]
IMPLICITY Raises $23M to Broaden Use of Its Cardiac Remote Monitoring Platform
IMPLICITY ®,a, leader in remote patient monitoring and cardiac data management solutions, today announced it […]
Twice-yearly Injection to Treat High Blood Pressure Could Replace Daily Pills
If successful, the study by Queen Mary University of London and Barts Health NHS Trust […]
Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.
Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for […]
Abbott Strengthens Its Connected Care Technologies with Latest Neurosphere™ Mypath™ Digital Health App
Abbott (NYSE: ABT) today announced that it has launched an upgraded version of its NeuroSphere™ […]
GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DNA Digital Data Storage
GenScript USA Inc., the world’s leading life science research tools and services provider, announced today the debut […]
Cannabotech's Botanical Drug for Pancreatic Cancer Has Demonstrated Killing 100% of Cancer Cells Without Damaging the Healthy Cells in the Cell Model
Cannabotech (CNTC.TA), which is involved in the development of a botanical drug based on an extract […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more